New Study Shows Drug Combo Cuts Fast-Spreading Lung Cancer Deaths by 58%
A new study reveals that a combination of two drugs reduces the risk of death from fast-spreading lung cancer by up to 58%. Advances in treatment, including patient-specific vaccines, are improving outcomes and targeting tumors effectively, offering new hope to lung cancer patients who previously faced poor prognoses.
Jagran·


